Introduction The variable disease span of autosomal dominant polycystic kidney disease (ADPKD) helps it be vital that you develop biomarkers that may predict disease progression, from an individual perspective also to select patients for renoprotective treatment. show these markers are connected with ADPKD intensity, assessed simply because GFR and TKV.8, 9, 10, 11 Within this… Continue reading Introduction The variable disease span of autosomal dominant polycystic kidney disease